U.S. stock futures were mixed this morning, with the Dow futures falling more than 100 points on Monday.
Shares of Neurogene Inc. NGNE fell sharply in today's pre-market trading after the company announced it brought its high-dose gene therapy trial to a halt after a serious adverse event in a Rett syndrome patient.
Neurogene shares declined 37.7% to $21.50 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
- Rezolve AI Limited RZLV shares tumbled 16.1% to $2.29 in pre-market trading after dipping over 20% on Friday.
- Kingsoft Cloud Holdings Limited KC shares dipped 12.3% to $4.43 in pre-market trading after gaining around 9% on Friday. Kingsoft Cloud will release its unaudited financial results for the third quarter before the opening bell on Nov. 19.
- Luminar Technologies, Inc. LAZR tumbled 9.3% to $0.8890 in today's pre-market trading after declining around 5% on Friday.
- Omeros Corporation OMER shares fell 7% to $6.28 in pre-market trading.
- CompoSecure, Inc. CMPO shares declined 5.9% to $13.00 in pre-market trading.
- Amgen Inc. AMGN shares fell 5.4% to $266.21 in pre-market trading following a 4% decline on Friday.
- Intuitive Machines, Inc. LUNR shares fell 5% to $11.80 in pre-market trading after jumping 21% on Friday.
- ProQR Therapeutics N.V. PRQR shares fell 4% to $3.67 in pre-market trading.
- NVIDIA Corporation NVDA shares fell 2.4% to $138.51 in pre-market trading after declining more than 3% on Friday.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in